Mastering Immunity 2026 – Shanghai

Mastering Immunity 2026 – Shanghai, China

Immunogenicity Risk Management by Design for NMEs, Biologics and Complex Peptides

Monday 13 April – Tuesday 14 April 2026, In-person only

Gain practical insights based on real world experience across modalities and approaches:
  • Implications by drug type: mAbs, Bispecifics, Fusion Proteins, Cell & Gene Therapies, ADCs, Enzymes, Complex Peptides, ASO, Nucleic Acids, NMEs, Alternative Scaffolds
  • Implications by disease area: oncology, neurology, inflamation/autoimmunity/immunology, diabetes/obesity, hematology, rare diseases, and more
  • Navigating the evolving regulation: Interpreting and applying regulatory guidelines to shape robust, compliant development pathways
  • Understand assay types and how to use them: MHC-peptide binding, antigen presentation MAPPs, T cell and DC-T cell assays, ELISpot and MLR to de-risk drug candidates
Who will be attending?
  • Biotherapeutics and Complex Peptide Drug Developers
  • Regulatory Authorities
  • Researchers with an interest in the field
  • China based developers wishing to commercialize drugs in world markets, including the USA and Europe
  • Companies wishing to commercialize drugs in China wishing to gain a better understanding of the regulatory environment and opportunities in China

Register Now – Early Bird Discount Until 31 January 2026

 

This in-person symposium in Shanghai brings together leaders in the biopharmaceutical industry around the world to discuss current and emerging best practice for managing immunogenicity risk in pharmaceutical development. We provide a particular focus around the rapidly evolving pharmaceutical development landscape in China and combine this with our speaker’s prior experience in the United States, Europe, and around the world in successfully managing immunogenicity risk over the last two decades.

Confirmed Speakers (More coming soon…)

Dr. Kanthikiran Varanasi
Global Head of Clinical Affairs
Galenicum
India





Dr. Tim Hickling
Consultant
Quasor
United Kingdom
Dr. Zuben Sauna
Director in Center for Biologics
Evaluation and Research
FDA
United States of America
Prof. Yoonjoo Choi
Professor in Department of
Microbiology and Immunology
Chonnam National University
Medical School
South Korea

Highlights from Previous Mastering Immunity Meetings are available online free of charge

Key moments captured from Mastering Immunity 2025 – Singapore held on 1-2 September 2025


ProImmune: Your Strategic Partner in Decoding Immunity

For 25 years, we’ve been pioneers in immunology research tools. We provide scientists with the innovative technologies – from MHC Multimer/Monomer products to our specialist in vitro and cell-based assay services to our groundbreaking Ankyron® platform.

By hosting global “Mastering Immunity” symposia, we connect the brightest minds to share cutting-edge knowledge and drive the field forward.

Price

Early Bird Registration** (Till 31 January 2026)
USD1,250 / EUR1,080 / GBP950 / CNY8,900
Standard Registration
USD1,950 / EUR1,685 / GBP1,485 / CNY13,900
*Other countries are invoiced in GBP, with the exception of the USA and Canada, which are invoiced in USD, China invoiced in CNY.
EUR are applicable for the following countries highlighted in the table here
**Free admission is available to the first 100 undergraduate and graduate students, as well as early-career scientists, upon submission of a brief justification in the application form.

    Registration Form:

    Please ensure your email is correct to avoid delays. A member of our team will then contact you shortly to guide you through the final steps and complete your registration for the meeting.

















    By submitting this form, I agree to the following terms, as applicable:

    ALL DELEGATES: I authorise and acknowledge that photographs, videos and/or direct quotes of speakers and attendees participating in this meeting are the sole property of ProImmune Ltd. for use and distribution for a variety of purposes including, but not limited to, publications, promotional brochures and other similar lawful purposes.

    FOR SPEAKERS ONLY IN ADDITION: As a speaker, I authorize ProImmune to use my name, photo, and biographical data in connection with the use and promotion of the program. I agree that ProImmune Ltd. may record my talk, reproduce handouts of my presentation and reproduce/distribute/deal with related materials using any form of media existing now or in the future, including online audio and video, transcripts, proceedings, and the like. I understand that I am not precluded in any way from using my presentation in the future in my own professional or personal work. To the best of my knowledge, my presentation does not violate any proprietary or personal rights of others (including copyright, trademark, and intellectual property and privacy rights) and is factually accurate. I confirm that I have the full authority to enter into this agreement and have obtained all necessary permissions or licenses from any individuals or organizations whose material is included or used in my presentation.

    By submitting this form, I also accept that my personal data will be used to process my order, support your experience throughout this website, and for other purposes described in our Privacy policy.

    I agree to the above statement and I have read and agree to ProImmune's Terms and conditions*

    For all Conference Enquiries:

    Email: enquiries@proimmune.com